Status:

UNKNOWN

Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation

Lead Sponsor:

Federal University of Health Science of Porto Alegre

Conditions:

Stem Cell Transplantation

Eligibility:

All Genders

18-64 years

Phase:

NA

Brief Summary

Hematological neoplasms originate from the differentiation and proliferation of abnormal lymphatic or myeloid cells that alter the constitution of elements of the blood, bone marrow and lymph nodes. T...

Detailed Description

This is a randomized clinical trial. Patients will be allocated into groups (1) Aerobic; (2) Anaerobic and (3) Mixed. The manifestation of signs and symptoms will be evaluated using the Edmonton Sympt...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Be between 18 and 64 years old;
  • Present hematological malignancy undergoing first antineoplastic treatment with HSCT;
  • Have intact neurological function and cognition;
  • Be in clinical conditions that allow participation in physical rehabilitation;
  • To agree with the study proposal by signing the Free and Informed Consent Form (TCLE).
  • Exclusion criteria:
  • Present clinical complications that impair the performance of motor physiotherapy, including the practice of cycle ergometer and resistance exercises;
  • Present previous musculoskeletal changes that interfere with the execution of physical performance assessment tests;
  • Patients with limiting cardiovascular or pulmonary disease, significant psychiatric or neurological disorders and/or limiting interpretation of documents and forms that will be used in the study;
  • Patients who require mobility assistance and/or diagnosed with multiple myeloma with or without the presence of bone metastasis;

Exclusion

    Key Trial Info

    Start Date :

    March 7 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2024

    Estimated Enrollment :

    93 Patients enrolled

    Trial Details

    Trial ID

    NCT06134297

    Start Date

    March 7 2022

    End Date

    December 1 2024

    Last Update

    November 18 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Santa Casa de Misericórdia de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil, 90020-090